Schedule 13G ownership disclosure
OptimizeRx Corp
Security class unavailable · CUSIP: 68401U105
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,569,044
- Percent of class
- 8.6400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-17-000239
- Form type
- SC 13G
- Filer
- OptimizeRx Corp
- CIK
- CIK 1448431
- Filed
- Jan 17, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership